In 2021, CCRM and CellCAN launched the Canadian Advanced Therapies Training Institute (CATTI) to address the talent shortage in Canada’s biomanufacturing workforce. Watch the video to learn more about CATTI’s best-in-class training programs, featuring (in order):
Craig Hasilo, Chief Scientific Officer, CATTI
Vanessa Laflamme, Chief Executive Officer, CATTI
Michael May, President and CEO, CCRM, and member of CATTI’s Board of Directors
William Brock, Chairman of the Board for CATTI and CellCAN